62.81% CAGR Therapeutic Vaccines Market Growth to 2018 Forecasts a Global Report at Sandlerresearch.org

Global Therapeutic Vaccines Market 2014-2018 a new research report added to Sandlerresearch.org store.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Dallas, TX (PRWEB) April 02, 2014

A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.

The analysts forecast the Global Therapeutic Vaccines market to grow at a CAGR of 62.81 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.

The Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  •     Americas
  •     EMEA
  •     APAC

Key Vendors

  •     Agenus Inc.
  •     Bavarian Nordic A/S.
  •     Dendreon Corp.
  •     GlaxoSmithKline plc
  •     Novartis International AG

Other Prominent Vendors

  •     AFFiRiS AG.
  •     Argos Therapeutics Inc.
  •     Celldex Therapeutics Inc.
  •     CEL-SCI Corp.
  •     Cytos Biotechnology AG
  •     GlobeImmune Inc.
  •     NewLink Genetics Corp.
  •     NovaRx Corp.
  •     Oncothyreon Inc.
  •     TVAX Biomedical Inc.
  •     TapImmune Inc.
  •     Vical Inc.
  •     Vaccinogen Inc.

Purchase Report @ http://www.sandlerresearch.org/purchase?rname=16028.

Market Driver

  •     Increase in Incidence of Cancer, Infectious Diseases, and Physiological Disorders
  •     Ongoing Development of a Large Number of Therapeutic Vaccines

Market Challenge

  •     Stringent Regulations
  •     Adverse Side Effects of Therapeutic Vaccines

Market Trend

  •     Improved Understanding of Immunology and Immunotherapy
  •     Increase in Mergers and Acquisitions

Key Questions Answered in this Report

  •     What will the market size be in 2018 and what will the growth rate be?
  •     What are the key market trends?
  •     What is driving this market?
  •     What are the challenges to market growth?
  •     Who are the key vendors in this market space?
  •     What are the market opportunities and threats faced by the key vendors?
  •     What are the strengths and weaknesses of the key vendors?

Other Related Reports:
Global Diabetic Nephropathy Market 2014-2018: The report covers the present scenario and the growth prospects of the Global Diabetic Nephropathy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various diabetic nephropathy drugs available in the market.

The Global Diabetic Nephropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Nephropathy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Global Pain Management Drugs Market 2014-2018: Analysts forecast the Global Pain Management Drugs market will grow at a CAGR of 3.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Pain Management Drugs market has also been witnessing intense competition among vendors. However, the increase in generic competition could pose a challenge to the growth of this market.

The key vendors dominating this space are Abbott Laboratories, Eli Lilly and Co., Endo Health Solutions Inc., Pfizer Inc., and Purdue Pharma L.P.

Global Generic Drugs Market 2014-2018: Analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market.

Explore other reports on Therapeutics Market.

About US:
Sandlerresearch.org (http://www.sandlerresearch.org/) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.


Contact

Follow us on: Contact's Google Plus

Past News Releases Group Rss Subscribe